Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 267

1.

Mutational Evolution in Relapsed Diffuse Large B-Cell Lymphoma.

Nijland M, Seitz A, Terpstra M, van Imhoff GW, Kluin PM, van Meerten T, Atayar Ç, van Kempen LC, Diepstra A, Kok K, van den Berg A.

Cancers (Basel). 2018 Nov 20;10(11). pii: E459. doi: 10.3390/cancers10110459.

2.

Core-binding factor acute myeloid leukemia with t(8;21): Risk factors and a novel scoring system (I-CBFit).

Ustun C, Morgan E, Moodie EEM, Pullarkat S, Yeung C, Broesby-Olsen S, Ohgami R, Kim Y, Sperr W, Vestergaard H, Chen D, Kluin PM, Dolan M, Mrózek K, Czuchlewski D, Horny HP, George TI, Kristensen TK, Ku NK, Yi CA, Møller MB, Marcucci G, Baughn L, Schiefer AI, Hilberink JR, Pullarkat V, Shanley R, Kohlschmidt J, Coulombe J, Salhotra A, Soma L, Cho C, Linden MA, Akin C, Gotlib J, Hoermann G, Hornick J, Nakamura R, Deeg J, Bloomfield CD, Weisdorf D, Litzow MR, Valent P, Huls G, Perales MA, Borthakur G.

Cancer Med. 2018 Sep;7(9):4447-4455. doi: 10.1002/cam4.1733. Epub 2018 Aug 16.

3.

Validation of a whole-slide image-based teleconsultation network.

Baidoshvili A, Stathonikos N, Freling G, Bart J, 't Hart N, van der Laak J, Doff J, van der Vegt B, Kluin PM, van Diest PJ.

Histopathology. 2018 Nov;73(5):777-783. doi: 10.1111/his.13673. Epub 2018 Aug 13.

PMID:
29893996
4.

Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens.

Oosten LEM, Chamuleau MED, Thielen FW, de Wreede LC, Siemes C, Doorduijn JK, Smeekes OS, Kersten MJ, Hardi L, Baars JW, Demandt AMP, Stevens WBC, Nijland M, van Imhoff GW, Brouwer R, Uyl-de Groot CA, Kluin PM, de Jong D, Veelken H.

Ann Hematol. 2018 Feb;97(2):255-266. doi: 10.1007/s00277-017-3167-7. Epub 2017 Dec 6.

5.

Combined loss of HLA I and HLA II expression is more common in the non-GCB type of diffuse large B cell lymphoma.

van der Meeren LE, Visser L, Diepstra A, Nijland M, van den Berg A, Kluin PM.

Histopathology. 2018 Apr;72(5):886-888. doi: 10.1111/his.13445. Epub 2018 Jan 29. No abstract available.

PMID:
29194719
6.

MYC expression and translocation analyses in low-grade and transformed follicular lymphoma.

Aukema SM, van Pel R, Nagel I, Bens S, Siebert R, Rosati S, van den Berg E, Bosga-Bouwer AG, Kibbelaar RE, Hoogendoorn M, van Imhoff GW, Kluin-Nelemans HC, Kluin PM, Nijland M.

Histopathology. 2017 Dec;71(6):960-971. doi: 10.1111/his.13316. Epub 2017 Oct 17.

PMID:
28730642
7.

HLA dependent immune escape mechanisms in B-cell lymphomas: Implications for immune checkpoint inhibitor therapy?

Nijland M, Veenstra RN, Visser L, Xu C, Kushekhar K, van Imhoff GW, Kluin PM, van den Berg A, Diepstra A.

Oncoimmunology. 2017 Mar 3;6(4):e1295202. doi: 10.1080/2162402X.2017.1295202. eCollection 2017.

8.

FcRL4+ B-cells in salivary glands of primary Sjögren's syndrome patients.

Haacke EA, Bootsma H, Spijkervet FKL, Visser A, Vissink A, Kluin PM, Kroese FGM.

J Autoimmun. 2017 Jul;81:90-98. doi: 10.1016/j.jaut.2017.03.012. Epub 2017 Apr 6.

PMID:
28390747
9.

B-Lymphoblastic Lymphomas Evolving from Follicular Lymphomas Co-Express Surrogate Light Chains and Mutated Gamma Heavy Chains.

Slot LM, Hoogeboom R, Smit LA, Wormhoudt TA, Biemond BJ, Oud ME, Schilder-Tol EJ, Mulder AB, Jongejan A, van Kampen AH, Kluin PM, Guikema JE, Bende RJ, van Noesel CJ.

Am J Pathol. 2016 Dec;186(12):3273-3284. doi: 10.1016/j.ajpath.2016.07.027. Epub 2016 Oct 15.

PMID:
27750045
10.

ARTISAN PCR: rapid identification of full-length immunoglobulin rearrangements without primer binding bias.

Koning MT, Kiełbasa SM, Boersma V, Buermans HPJ, van der Zeeuw SAJ, van Bergen CAM, Cleven AHG, Kluin PM, Griffioen M, Navarrete MA, Veelken H.

Br J Haematol. 2017 Sep;178(6):983-986. doi: 10.1111/bjh.14180. Epub 2016 Jun 15. No abstract available.

PMID:
27301611
11.

Proteomics Based Identification of Proteins with Deregulated Expression in B Cell Lymphomas.

Wu R, Nijland M, Rutgers B, Veenstra R, Langendonk M, van der Meeren LE, Kluin PM, Li G, Diepstra A, Chiu JF, van den Berg A, Visser L.

PLoS One. 2016 Jan 11;11(1):e0146624. doi: 10.1371/journal.pone.0146624. eCollection 2016.

12.

Better survival of renal cell carcinoma in patients with inflammatory bowel disease.

Derikx LA, Nissen LH, Drenth JP, van Herpen CM, Kievit W, Verhoeven RH, Mulders PF, Hulsbergen-van de Kaa CA, Boers-Sonderen MJ, van den Heuvel TR, Pierik M, Nagtegaal ID, Hoentjen F; Dutch Initiative on Crohn and Colitis; PALGA Group; IBD/RCC Group.

Oncotarget. 2015 Nov 10;6(35):38336-47. doi: 10.18632/oncotarget.5186.

13.

Sequential karyotyping in Burkitt lymphoma reveals a linear clonal evolution with increase in karyotype complexity and a high frequency of recurrent secondary aberrations.

Aukema SM, Theil L, Rohde M, Bauer B, Bradtke J, Burkhardt B, Bonn BR, Claviez A, Gattenlöhner S, Makarova O, Nagel I, Oschlies I, Pott C, Szczepanowski M, Traulsen A, Kluin PM, Klapper W, Siebert R, Murga Penas EM.

Br J Haematol. 2015 Sep;170(6):814-25. doi: 10.1111/bjh.13501. Epub 2015 Jun 24.

PMID:
26104998
14.

Paediatric nodal marginal zone B-cell lymphadenopathy of the neck: a Haemophilus influenzae-driven immune disorder?

Kluin PM, Langerak AW, Beverdam-Vincent J, Geurts-Giele WR, Visser L, Rutgers B, Schuuring E, Van Baarlen J, Lam KH, Seldenrijk K, Kibbelaar RE, de Wit P, Diepstra A, Rosati S, van Noesel MM, Zwaan CM, Hunting JC, Hoogendoorn M, van der Gaag EJ, van Esser JW, de Bont E, Kluin-Nelemans HC, Winter RH, Lo Ten Foe JR, van der Zanden AG.

J Pathol. 2015 Jul;236(3):302-14. doi: 10.1002/path.4524. Epub 2015 Apr 8.

PMID:
25722108
15.

18F-FDG PET increases visibility of bone lesions in relapsed multiple myeloma: is this hypoxia-driven?

de Waal EG, Slart RH, Leene MJ, Kluin PM, Vellenga E.

Clin Nucl Med. 2015 Apr;40(4):291-6. doi: 10.1097/RLU.0000000000000629.

PMID:
25546223
16.

Diffuse large B cell lymphomas relapsing in the CNS lack oncogenic MYD88 and CD79B mutations.

Kersten MJ, Kraan W, Doorduijn J, Bromberg J, Lam K, Kluin PM, van der Holt BJ, Spaargaren M, Pals ST.

Blood Cancer J. 2014 Dec 12;4:e266. doi: 10.1038/bcj.2014.87. No abstract available.

17.

Epstein-Barr virus, the germinal centre and the development of Hodgkin's lymphoma.

Mohamed G, Vrzalikova K, Cader FZ, Vockerodt M, Nagy E, Flodr P, Yap LF, Diepstra A, Kluin PM, Rosati S, Murray P.

J Gen Virol. 2014 Sep;95(Pt 9):1861-9. doi: 10.1099/vir.0.066712-0. Epub 2014 Jun 3.

PMID:
24893782
18.

The missing link in early follicular lymphoma development.

Kluin PM.

Blood. 2014 May 29;123(22):3371-2. doi: 10.1182/blood-2014-04-566828. No abstract available.

19.

CD30 in systemic mastocytosis.

van Anrooij B, Kluin PM, Oude Elberink JN, Kluin-Nelemans JC.

Immunol Allergy Clin North Am. 2014 May;34(2):341-55. doi: 10.1016/j.iac.2014.01.006. Epub 2014 Mar 13. Review.

PMID:
24745678
20.

Disturbed B cell homeostasis in newly diagnosed giant cell arteritis and polymyalgia rheumatica.

van der Geest KS, Abdulahad WH, Chalan P, Rutgers A, Horst G, Huitema MG, Roffel MP, Roozendaal C, Kluin PM, Bos NA, Boots AM, Brouwer E.

Arthritis Rheumatol. 2014 Jul;66(7):1927-38. doi: 10.1002/art.38625.

21.

Pain and anxiety during bone marrow biopsy.

Tanasale B, Kits J, Kluin PM, Trip A, Kluin-Nelemans HC.

Pain Manag Nurs. 2013 Dec;14(4):310-317. doi: 10.1016/j.pmn.2011.06.007. Epub 2011 Oct 17.

PMID:
24315253
22.

High prevalence of oncogenic MYD88 and CD79B mutations in primary testicular diffuse large B-cell lymphoma.

Kraan W, van Keimpema M, Horlings HM, Schilder-Tol EJ, Oud ME, Noorduyn LA, Kluin PM, Kersten MJ, Spaargaren M, Pals ST.

Leukemia. 2014 Mar;28(3):719-20. doi: 10.1038/leu.2013.348. Epub 2013 Nov 20. No abstract available.

PMID:
24253023
23.

Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma.

Aukema SM, Kreuz M, Kohler CW, Rosolowski M, Hasenclever D, Hummel M, Küppers R, Lenze D, Ott G, Pott C, Richter J, Rosenwald A, Szczepanowski M, Schwaenen C, Stein H, Trautmann H, Wessendorf S, Trümper L, Loeffler M, Spang R, Kluin PM, Klapper W, Siebert R; Molecular Mechanisms in Malignant Lymphomas Network Project.

Haematologica. 2014 Apr;99(4):726-35. doi: 10.3324/haematol.2013.091827. Epub 2013 Oct 31.

24.

Prognostic significance of HIF-1a, CA-IX, and OPN in T1-T2 laryngeal carcinoma treated with radiotherapy.

Wachters JE, Schrijvers ML, Slagter-Menkema L, Mastik M, de Bock GH, Langendijk JA, Kluin PM, Schuuring E, van der Laan BF, van der Wal JE.

Laryngoscope. 2013 Sep;123(9):2154-60.

PMID:
24167820
25.

High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites.

Kraan W, Horlings HM, van Keimpema M, Schilder-Tol EJ, Oud ME, Scheepstra C, Kluin PM, Kersten MJ, Spaargaren M, Pals ST.

Blood Cancer J. 2013 Sep 6;3:e139. doi: 10.1038/bcj.2013.28.

26.

Origin and migration of follicular lymphoma cells.

Kluin PM.

Haematologica. 2013 Sep;98(9):1331-3. doi: 10.3324/haematol.2013.091546. No abstract available.

27.

Hypoglycemia in a patient with a big "big"-IGF-II-producing tumor.

Alkemade GM, Bakker M, Rikhof B, IJpma FF, van Ginkel RJ, Kluin PM, van Doorn J, Dullaart RP.

J Clin Endocrinol Metab. 2013 Aug;98(8):3113-4. doi: 10.1210/jc.2013-2170. Epub 2013 Jun 20. No abstract available.

PMID:
23788691
28.

FADD expression is associated with regional and distant metastasis in squamous cell carcinoma of the head and neck.

Pattje WJ, Melchers LJ, Slagter-Menkema L, Mastik MF, Schrijvers ML, Gibcus JH, Kluin PM, Hoegen-Chouvalova O, van der Laan BF, Roodenburg JL, van der Wal JE, Schuuring E, Langendijk JA.

Histopathology. 2013 Aug;63(2):263-70. doi: 10.1111/his.12174. Epub 2013 Jun 13.

PMID:
23763459
29.

A single center analysis of nucleophosmin in acute myeloid leukemia: value of combining immunohistochemistry with molecular mutation analysis.

Woolthuis CM, Mulder AB, Verkaik-Schakel RN, Rosati S, Diepstra A, van den Berg E, Schuringa JJ, Vellenga E, Kluin PM, Huls G.

Haematologica. 2013 Oct;98(10):1532-8. doi: 10.3324/haematol.2012.079806. Epub 2013 May 28.

30.

Overlapping immunoglobulin G4-related disease and Rosai-Dorfman disease mimicking lung cancer.

de Jong WK, Kluin PM, Groen HM.

Eur Respir Rev. 2012 Dec 1;21(126):365-7. doi: 10.1183/09059180.00001612. No abstract available.

31.

Evaluation of the appendix during diagnostic laparoscopy, the laparoscopic appendicitis score: a pilot study.

Hamminga JT, Hofker HS, Broens PM, Kluin PM, Heineman E, Haveman JW.

Surg Endosc. 2013 May;27(5):1594-600. doi: 10.1007/s00464-012-2634-4. Epub 2012 Oct 17.

PMID:
23073690
32.

Contribution of highly sensitive diagnostic methods to the diagnosis of systemic mastocytosis in the absence of skin lesions.

Alvarez-Twose I, Matito A, Sánchez-Muñoz L, Morgado JM, Orfao A, Escribano L, van Doormaal JJ, van der Veer E, van Voorst Vader PC, Kluin PM, Mulder AB, van der Heide S, Arends S, Kluin-Nelemans JC, Oude Elberink JN, de Monchy JG.

Allergy. 2012 Sep;67(9):1190-1. doi: 10.1111/j.1398-9995.2012.02850.x. No abstract available.

PMID:
22882359
33.

Adrenal hemorrhage causing adrenal insufficiency in a patient with antiphospholipid syndrome: increased adrenal 18F-FDG uptake.

Boneschansker L, Nijland M, Glaudemans AW, van der Meulen SB, Kluin PM, Dullaart RP.

J Clin Endocrinol Metab. 2012 Sep;97(9):3014-5. doi: 10.1210/jc.2012-2050. Epub 2012 Jun 14. No abstract available.

PMID:
22701015
34.

Tryptase and histamine metabolites as diagnostic indicators of indolent systemic mastocytosis without skin lesions.

van Doormaal JJ, van der Veer E, van Voorst Vader PC, Kluin PM, Mulder AB, van der Heide S, Arends S, Kluin-Nelemans JC, Oude Elberink JN, de Monchy JG.

Allergy. 2012 May;67(5):683-90. doi: 10.1111/j.1398-9995.2012.02809.x. Epub 2012 Mar 22.

PMID:
22435702
35.

Allogeneic stem-cell transplantation for blastic plasmacytoid dendritic cell neoplasm.

Ham JC, Janssen JJ, Boers JE, Kluin PM, Verdonck LF.

J Clin Oncol. 2012 Mar 10;30(8):e102-3. doi: 10.1200/JCO.2011.35.8143. Epub 2012 Feb 13. No abstract available.

PMID:
22331943
36.

Downregulation of MEIS1 impairs long-term expansion of CD34+ NPM1-mutated acute myeloid leukemia cells.

Woolthuis CM, Han L, Verkaik-Schakel RN, van Gosliga D, Kluin PM, Vellenga E, Schuringa JJ, Huls G.

Leukemia. 2012 Apr;26(4):848-53. doi: 10.1038/leu.2011.277. Epub 2011 Oct 11. No abstract available.

PMID:
21986840
37.

Treatment of mucosa-associated lymphoid tissue lymphoma in Sjogren's syndrome: a retrospective clinical study.

Pollard RP, Pijpe J, Bootsma H, Spijkervet FK, Kluin PM, Roodenburg JL, Kallenberg CG, Vissink A, van Imhoff GW.

J Rheumatol. 2011 Oct;38(10):2198-208. doi: 10.3899/jrheum.110077. Epub 2011 Aug 15.

PMID:
21844152
38.

[Benign histiocytosis: Rosai-Dorfman disease].

Noordzij W, Weernink EE, van Imhoff GW, Kluin PM, de Haan LD.

Ned Tijdschr Geneeskd. 2011;155(27):A3176. Dutch.

PMID:
21771370
39.

Gene expression profiling in the leukemic stem cell-enriched CD34+ fraction identifies target genes that predict prognosis in normal karyotype AML.

de Jonge HJ, Woolthuis CM, Vos AZ, Mulder A, van den Berg E, Kluin PM, van der Weide K, de Bont ES, Huls G, Vellenga E, Schuringa JJ.

Leukemia. 2011 Dec;25(12):1825-33. doi: 10.1038/leu.2011.172. Epub 2011 Jul 15.

PMID:
21760593
40.

F-18 FLT PET: a noninvasive diagnostic tool for visualization of the bone marrow compartment in patients with aplastic anemia: a pilot study.

Agool A, Slart RH, Kluin PM, de Wolf JT, Dierckx RA, Vellenga E.

Clin Nucl Med. 2011 Apr;36(4):286-9. doi: 10.1097/RLU.0b013e31820aa1a1.

PMID:
21368602
41.

Double-hit B-cell lymphomas.

Aukema SM, Siebert R, Schuuring E, van Imhoff GW, Kluin-Nelemans HC, Boerma EJ, Kluin PM.

Blood. 2011 Feb 24;117(8):2319-31. doi: 10.1182/blood-2010-09-297879. Epub 2010 Nov 30. Review.

42.

Ki-67 as a prognostic marker in mantle cell lymphoma-consensus guidelines of the pathology panel of the European MCL Network.

Klapper W, Hoster E, Determann O, Oschlies I, van der Laak J, Berger F, Bernd HW, Cabeçadas J, Campo E, Cogliatti S, Hansmann ML, Kluin PM, Kodet R, Krivolapov YA, Loddenkemper C, Stein H, Möller P, Barth TE, Müller-Hermelink K, Rosenwald A, Ott G, Pileri S, Ralfkiaer E, Rymkiewicz G, van Krieken JH, Wacker HH, Unterhalt M, Hiddemann W, Dreyling M; European MCL Network.

J Hematop. 2009 Jul;2(2):103-11. doi: 10.1007/s12308-009-0036-x. Epub 2009 Jun 16.

43.

Somatostatin receptor scintigraphy might be useful for detecting skeleton abnormalities in patients with multiple myeloma and plasmacytoma.

Agool A, Slart RH, Dierckx RA, Kluin PM, Visser L, Jager PL, Vellenga E.

Eur J Nucl Med Mol Imaging. 2010 Jan;37(1):124-30. doi: 10.1007/s00259-009-1199-5.

44.

miRNA profiling of B-cell subsets: specific miRNA profile for germinal center B cells with variation between centroblasts and centrocytes.

Tan LP, Wang M, Robertus JL, Schakel RN, Gibcus JH, Diepstra A, Harms G, Peh SC, Reijmers RM, Pals ST, Kroesen BJ, Kluin PM, Poppema S, van den Berg A.

Lab Invest. 2009 Jun;89(6):708-16. doi: 10.1038/labinvest.2009.26. Epub 2009 Apr 6.

45.

Hypermutation in mantle cell lymphoma does not indicate a clinical or biological subentity.

Schraders M, Oeschger S, Kluin PM, Hebeda K, Schuuring E, Groenen PJ, Hansmann ML, van Krieken JH.

Mod Pathol. 2009 Mar;22(3):416-25. doi: 10.1038/modpathol.2008.199. Epub 2009 Jan 9.

46.

Cavitating lymph node syndrome.

de Vries AP, Bakker SJ, Kallenberg CG, Gans RO, Bongaerts AH, Kluin PM.

Neth J Med. 2008 Oct;66(9):403-4. No abstract available.

47.

Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge.

Boerma EG, Siebert R, Kluin PM, Baudis M.

Leukemia. 2009 Feb;23(2):225-34. doi: 10.1038/leu.2008.281. Epub 2008 Oct 16. Review.

PMID:
18923440
48.

Genomic alterations and gene expression in primary diffuse large B-cell lymphomas of immune-privileged sites: the importance of apoptosis and immunomodulatory pathways.

Booman M, Szuhai K, Rosenwald A, Hartmann E, Kluin-Nelemans H, de Jong D, Schuuring E, Kluin P.

J Pathol. 2008 Oct;216(2):209-17. doi: 10.1002/path.2399.

PMID:
18729069
49.

Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy.

Schrijvers ML, van der Laan BF, de Bock GH, Pattje WJ, Mastik MF, Menkema L, Langendijk JA, Kluin PM, Schuuring E, van der Wal JE.

Int J Radiat Oncol Biol Phys. 2008 Sep 1;72(1):161-9. doi: 10.1016/j.ijrobp.2008.05.025.

PMID:
18722267
50.

Chromosomal alterations detected by comparative genomic hybridization in subgroups of gene expression-defined Burkitt's lymphoma.

Salaverria I, Zettl A, Beà S, Hartmann EM, Dave SS, Wright GW, Boerma EJ, Kluin PM, Ott G, Chan WC, Weisenburger DD, Lopez-Guillermo A, Gascoyne RD, Delabie J, Rimsza LM, Braziel RM, Jaffe ES, Staudt LM, Müller-Hermelink HK, Campo E, Rosenwald A; Leukemia and Lymphoma Molecular Profiling Project (LLMPP).

Haematologica. 2008 Sep;93(9):1327-34. doi: 10.3324/haematol.13071. Epub 2008 Aug 12.

Supplemental Content

Loading ...
Support Center